Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of ceftazidime-avibactam for carbapenem-resistant gram-negative pulmonary infection in Chinese adults
ChiCTR2400080479Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jan 2024
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ceftazidime + avibactam, sponsored by Ruijin Hospital. Started Jan 2024; status: recruiting.
02
Drugs
ceftazidime + avibactam
Beyond the preview
Go deeper on ChiCTR2400080479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080479.